Navigation Links
Hawkins, Inc. Declares Semi-Annual Cash Dividend Of $0.34 Per Share

MINNEAPOLIS, Aug. 2, 2012 /PRNewswire/ -- The Board of Directors of Hawkins, Inc. (Nasdaq:   HWKN), at its meeting on August 2, 2012, declared a semi-annual cash dividend of $0.34 per share payable October 5, 2012, to shareholders of record at the close of business on September 21, 2012.  This is the 27th consecutive year the Company has paid cash dividends since it first began paying out dividends in 1985.

Hawkins, Inc. distributes, blends and manufactures bulk and specialty chemicals for its customers in a wide variety of industries. Headquartered in Minneapolis, Minnesota, and with 25 facilities in 13 states, the Company creates value for its customers through superb customer service and support, quality products and personalized applications.

SOURCE Hawkins, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Young Innovations, Inc. Board Of Directors Declares Quarterly Dividend
2. Lilly Declares Third-Quarter 2012 Dividend, Resumes Share Repurchase Program
3. Young Innovations, Inc. Board of Directors Declares Quarterly Dividend
4. BD Board Declares Dividend
5. Hill-Rom Announces Third Quarter 2012 Dividend
6. Heska Announces Quarterly Dividend of $0.10 Per Share
7. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
8. Zimmer Announces Quarterly Dividend for Second Quarter of 2012
9. Cantel Medical Board Of Directors Authorizes Regular Semiannual Dividend
10. Kensey Nash Agrees to Be Acquired by DSM for $38.50 per Share in Cash
11. ResearchMoz: Telemedicine Monitoring Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018 - Market Research Report
Post Your Comments:
(Date:12/1/2015)... 1, 2015 Russia has always ... 70% of new drugs registered in Europe in ... --> Russia has always been a country ... drugs registered in Europe in 2015 were tested ... Russia has always been a country of choice ...
(Date:12/1/2015)... Dec. 1, 2015 Relmada Therapeutics, Inc. (OTCQB: RLMD), ... chronic pain, announced today that the company will present at ... December 1-3 at the Luxe Sunset Boulevard Hotel in ... CEO of Relmada Therapeutics, will present on Thursday, December 3, ... . Please register at least 10 minutes prior ...
(Date:12/1/2015)...   MabVax Therapeutics Holdings, Inc . (OTCQB: MBVX), ... filed an Investigational New Drug Application (IND) with the ... lead fully human antibody product HuMab 5B1 as a ... initiate the Phase I clinical trial early in 2016. ... The planned Phase I trial will evaluate the safety, ...
Breaking Medicine Technology:
(Date:12/1/2015)... ... 2015 , ... CloudLIMS today announced that it is the ... the New Products and Services category for its innovative product offering, BioTracer. ... that helps labs organize data and track samples with storage inventories. BioTracer's SaaS ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... must mark the film for accurate interpretation by the radiologist. The marking utensils ... inventor from Sacramento, Calif., has found a way to alleviate this problem. , ...
(Date:12/1/2015)... ... 2015 , ... McLean, VA., December 1, 2015 - Octo ... sprint agile development contract to support the National Geospatial-Intelligence Agency's (NGA) IT Services ... engineering, infrastructure, as well as operations and sustainment support to the NGA’s Agile ...
(Date:12/1/2015)... GA (PRWEB) , ... December 01, 2015 , ... ... supports SACC-GA and SACC-USA through membership and leadership since 2008. Gary ... Chair for SACC-USA . Gary has spent a significant amount of time ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes Tympani as ... Cisco Unified Contact Center solutions targeted to the high-end enterprise contact center marketplace. ...
Breaking Medicine News(10 mins):